Paxalisib Active Not Recruiting Phase 2 Trials for Recurrent WHO Grade III Glioma / Recurrent Diffuse Intrinsic Pontine Glioma / Diffuse Intrinsic Pontine Gliomas (DIPG) / Diffuse Midline Glioma, H3 K27M-Mutant / WHO Grade III Gliomas / Recurrent Diffuse Midline Glioma, H3 K27M-Mutant Treatment